Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Safety topic
No spam. Unsubscribe anytime.
CDS-CC reviews February safety misses; board delays adoption of epinephrine and naloxone policies
Summary
Executive Director Nathan Grotrian reported two safety misses in February and action plans; the board reviewed drafted Stock Epinephrine/Allergy Management and Drug Overdose/Naloxone policies but requested legal and medical review and did not adopt them.
Executive Director Nathan Grotrian told the board that the center recorded two safety "misses" in February — one during Valentine's Day activities and a second later that week — and that neither incident was egregious. Grotrian said action plans were developed and no major accidents or injuries occurred during the month.
The board reviewed two drafted health and safety policies: a Stock Epinephrine and Allergy Management Policy and a Drug Overdose and Naloxone Administration Policy. Several board members raised questions about the drafts and the board decided not to adopt the policies at this meeting, requesting additional feedback from legal and medical professionals before reconsideration.
